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Abstract
Attention deficit hyperactivity disorder (ADHD) is a mental disorder of the 
neurodevelopmental type. The disorder represents one of the common causes of 
referral for behavioral problems in children to medical and mental health doctors 
all around the world. The diagnosis can be done by DSM-V criteria. According 
to DSM-V, there are three main subtypes of ADHD: ADHD-inattentive type, 
ADHD-hyperactive-impulsive type, and ADHD-combined type. The etiology of 
ADHD is not definitively known. A genetic imbalance of catecholamine metabo-
lism in the cerebral cortex appears to play a primary role. Various environmental 
factors may play a secondary role. Cognitive impairments in a variety of domains 
have been found in ADHD as well as impairment in overall intellectual function. 
A meta-analysis of children and adolescents with ADHD showed impairments in 
several aspects of executive functioning. The most important part of any inter-
vention plan for a child with ADHD is the physical, behavioral and neuromotor/
neuropsychological examination. Medication should be started with one of the 
stimulants. Both d-amphetamine and methylphenidate have been shown to be 
effective for improvement of hyperactivity, concentration problems, learning 
disorders, and other comorbidities.
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1. Introduction
Attention deficit hyperactivity disorder (ADHD) is a mental disorder of the 
neurodevelopmental type. It is characterized by difficulty paying attention, exces-
sive activity and acting without regards to consequences, which are otherwise not 
appropriate for a person’s age. The disorder represents one of the common causes of 
referral for behavioral problems in children to medical and mental health doctors all 
around the world. It is one of the most prevalent psychiatric conditions in children 
affecting 5% of children and adolescents worldwide. Symptoms which are specific 
for ADHD could decrease with age as almost 65% of children with ADHD have 
partial resolution of signs but 15% of ADHD children exhibit complete disappear-
ance of clinical picture in adulthood [1].
A meta-analysis of 175 research studies worldwide on ADHD prevalence in 
children aged 18 and under found an overall pooled estimate of 7.2% [2].
The number of children with ADHD can reach millions. According to data 
received in 2016 from USA almost 6.1 million of children have ADHD (9.4%). About 
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388,000 children are 2–5 years of age; 4 million children are 6–11 years; and 3 
million children aged 12–17 years. Boys are more likely to be diagnosed with ADHD 
than girls [3]. The prevalence age for diagnosis is 2–17 years.
Centers for Disease Control and prevention (CDC) uses datasets from parent 
surveys and healthcare claims to understand diagnosis and treatment patterns for 
ADHD. Estimates for diagnosis and treatment can vary depending on the source [4]. 
The methods used for ADHD assessment are also different.
Coexisting disorders are common in children with ADHD. According to a 
national 2016 parent survey every 6 in 10 children with ADHD could have at least 
one other mental, emotional or behavioral disorder; almost half of the children 
with ADHD have coexisting behavioral and conduct disorders. One third of ADHD 
children could exhibit anxiety disorders as well. Depression, autism spectrum dis-
order and Tourette syndrome are also common disorders accompanying ADHD [2].
The first information about ADHD appeared in 1865 while German doctor 
Heinrich Hoffman described hyperactive child (“Fidgety Phil”). The enormous sci-
entific contribution was done by George Still and Alfred Tregold who were the first 
authors to emphasize those clinical clues which still persist [5]. In 1922, the condition 
was called as “postencephalic behavior disorder”, later in 1947, it was changed with 
“brain-injured child,” then in 1963 it was renamed as “perceptually handicapped 
child” and ending with “minimal brain dysfunction” in 1966 [6]. Two years after in 
1968 Diagnostic and Statistical Manual (DSM) recognized it as a syndrome under 
the term “hyperkinetic reaction of childhood or adolescence.” In late 80s DSM-III 
recognized two subtypes of attention deficit disorder (ADD) with hyperactivity 
and ADD without hyperactivity. DSM-III revised the term ADD and changed it with 
“attention-deficit hyperactivity disorder (ADHD).” Finally DSM-IV identified three 
subtypes of the syndrome: ADHD-inattentive type, ADHD-hyperactive-impulsive 
type, and ADHD-combined type [7]. The DSM-V shared the same clinical forms of 
ADHD and identified strict diagnostic criteria for each [8].
2. DSM-5 diagnostic criteria
A. A persistent pattern of inattention and/or hyperactivity-impulsivity that 
interferes with functioning or development as characterized by (1) and/ 
or (2):
1. Inattention: Six (or more) of the following symptoms have persisted for 
at least 6 months to a degree that is inconsistent with developmental level 
and that negatively impact directly on social and academic/occupational 
activities.
Note: The symptoms are not solely a manifestation of oppositional behavior, 
defiance, hostility or failure to understand tasks or instructions. For older adoles-
cents and adults (age 17 and older) at least five symptoms are required.
a. Often fails to give close attention to details or make careless mistakes in 
schoolwork, at work or during other activities (e.g., overlooks or misses 
details, work is inaccurate).
b. Often has difficulty sustaining attention in tasks or play activities (e.g., 
has difficulty remaining focused during lectures, conversations or 
lengthy reading).
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c. Often does not seem to listen when spoken to directly (e.g., mind seems 
elsewhere, even in the absence of any obvious distraction).
d. Often does not follow through on instructions and fails to finish school-
work, chores, or duties in the workplace (e.g., starts tasks but quickly 
loses focus and is easily sidetracked).
e. Often has difficulty organizing tasks and activities (e.g., difficulty 
managing sequential tasks; difficulty keeping materials and belongings 
in order, messy, disorganized work; has poor time management; fails to 
meet deadlines).
f. Often avoids, dislikes or is reluctant to engage in tasks that require 
sustained mental effort (e.g., schoolwork or homework; for older 
adolescents and adult, preparing reports, completing forms, reviewing 
lengthy papers).
g. Often loses things necessary for tasks or activities (e.g., school materi-
als, pencils, books, tools, wallets, keys, paperwork, eyeglasses, mobile 
telephones).
h. Is often easily distracted by extraneous stimuli (for older adolescents 
and adults may include unrelated thoughts).
i. Is often forgetful in daily activities (e.g., doing chores, running errands; 
for older adolescents and adults returning calls, paying bills, keeping 
appointments).
2. Hyperactivity and impulsivity: Six (or more) of the following symptoms 
have persisted for at least 6 months to a degree that is inconsistent with 
developmental level and that negatively impacts directly on social and 
academic/occupational activities:
Note: The symptoms are not solely a manifestation of oppositional behavior, 
defiance, hostility or a failure to understand tasks or instructions. For older adoles-
cents and adults (age 17 and older) at least five symptoms are required.
a. Often fidgets with or taps hands or feet or squirms in a seat.
b. Often leaves seat in situations when remaining seated is expected (e.g., 
leaves his or her place in the classroom, in the office or other workplace 
or in other situations that require remaining in place).
c. Often runs about or climbs in situations where it is inappropriate (Note: 
In adolescents or adults may be limited to feeling restless).
d. Often unable to play or engage in leisure activities quietly.
e. Is often “on the go” acting as if “driven by a motor” (e.g., is unable to be 
or uncomfortable being still for extended time as in restaurants, meet-
ing; may be experienced by others as being restless or difficult to keep 
up with).
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f. Often talks excessively
g. Often blurts out an answer before a question has been com-
pleted (e.g., complete people’s sentences; cannot wait for turn in 
conversation).
h. Often has difficulty waiting his or her turn (e.g., while waiting  
in line).
i. Often interrupts or intrudes on others (e.g., butts into conversations, 
games or activities; may start using other people’s things without asking 
or receiving permission; for adolescents and adults, may intrude into or 
take over what others are doing).
B. Several inattentive or hyperactive-impulsive symptoms were present prior 
to age 12 years.
C. Several inattentive or hyperactive-impulsive symptoms are present in two 
or more setting (e.g., at home, school or work; with friends or relatives; in 
other activities).
D. There is clear evidence that the symptoms interfere with or reduce the 
quality of social, academic or occupational functioning.
E. The symptoms do not occur exclusively during the course of schizo-
phrenia or another psychotic disorder and are not better explained 
by another mental disorder (e.g., mood disorder, anxiety disorder, 
dissociative disorder, personality disorder, substance intoxication or 
withdrawal).
Specify whether
314.01 (F90.2) Combined presentation: If both criterion A1 (inattention) and 
criterion A2 (hyperactivity-impulsivity) are met for the past 6 months.
314.00 (F90.0) Predominantly inattentive presentation: If criterion A1 (inat-
tention) is met but criterion A2 (hyperactivity-impulsivity) is not met for the past 
6 months.
314.01 (F90.1) Predominantly hyperactive/impulsive presentation: If 
criterion A2 (hyperactivity-impulsivity) is met but criterion A1 (inattention) is not 
mere over the past 6 months.
Specify if:
In partial remission: When full criteria were previously met, fewer than the 
full criteria have been met for the past 6 months and the symptoms still result in 
impairment in social, academic or occupational functioning.
Specify current severity:
Mild: Few if any symptoms in excess of those required to make the diagnosis are 
present and symptoms result it only minor functional impairments.
Moderate: Symptoms or functional impairment between “mild” and “severe” 
are present and symptoms result in only minor functional impairments.
Severe: Many symptoms in excess of those required to make the diagnosis or 
several symptoms that are particularly severe, are present or the symptoms result in 
marked impairment is social or occupational functioning.
5Attention Deficit Hyperactivity Disorder
DOI: http://dx.doi.org/10.5772/intechopen.92334
2.1 Etiology
The etiology of ADHD is not definitely known. A genetic imbalance of cate-
cholamines in the cerebral cortex appears to play a primary role. A genetic contri-
bution to the pathogenesis of ADHD is supported by the increased risk of ADHD 
in the first-degree relatives of patients with ADHD and twin studies from different 
countries that consistently provide heritability estimates of approximately 75% [1].
Various environmental factors may play a secondary role; the significance of 
environmental factors is controversial. Dietary influences, sleep deficiency, prenatal 
medications, prematurity, iron deficiency, iodine deficiency and etc.
2.1.1 Dietary influences
The influence of diet on attention, hyperactivity, and behavior is controversial. 
Some children may demonstrate mild adverse behavioral effects of diets containing 
food additives, artificial colors, excess sugar, or reduced intake of essential fatty 
acids and minerals.
2.1.2 Food additives
Food additives were first suggested as potential cause of hyperactive behavior 
in the 1970. Systematic reviews and the meta-analyses of randomized trials with 
methodological limitations suggest that some children with ADHD respond 
favorably to elimination diets [9, 10]. However, this conclusion is not universally 
accepted, and the issue remains controversial.
2.1.3 Refined sugar
Adverse behavior effects including hyperactivity are commonly attributed to excess 
sugar intake by parents and teachers. Parent of children with ADHD frequently note a 
worsening of hyperactivity after consuming high carbohydrate meal. There are pro-
posed mechanisms: sensitivity to refined sugar and functional reactive hypoglycemia 
(which triggers release of stress hormones such as adrenaline) after ingesting sugar [11].
There is no evidence that sugar effects the behavior and/or cognitive perfor-
mance [11]. Future studies are necessary to confirm the effect on even a small 
subset of children.
2.1.4 Food sensitivity
Food allergy is proposed as a possible factor in the cause of ADHD. There 
are few well-designed trials evaluating the potential association between food 
sensitivity (allergy or intolerance) and behavior. Demonstration of such associa-
tion requires removal of the suspect food(s) from child’s diet (elimination diet). 
Followed by challenge with suspected food(s) versus placebo. The role of food 
sensitivity as a cause of ADHD is difficult to document, cooperation on neurolo-
gist, allergist and dietician being essential. The hypoallergic diet deserves further 
study [4].
2.1.5 Iron deficiency
The role of iron deficiency in the ADHD has not clearly defined. A com-
parison of clinical characteristics of children with the lowest serum ferritin 
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levels (20ng/ml) and those with highest serum ferritin levels (60ng/ml) show 
no significant difference in severity or frequency of ADHD and comorbid 
symptoms [4]. In addition, there appears to be an overlap between restless leg 
syndrome (which is associated with iron deficiency) and ADHD symptom in 
children [12].
2.1.6 Zinc deficiency
The role of zinc in ADHD is also controversial. Several studies have been con-
ducted to find out the role of zinc in the etiology of ADHD. Study by Arnold and 
colleagues [13] did not show that the zinc alone could improve the ADHD symp-
toms. In another study zinc was a part of the treatment [14]. In conclusion, zinc 
is tolerated well in children with ADHD. However, further evidences are required 
to indicate whether zinc is effective for treating children with ADHD. It is recom-
mended to replicate the randomized well-controlled trials [15].
2.1.7 Prenatal exposure to tobacco smoke
Prenatal exposure to tobacco smoke is consistently associated with development 
of ADHD in case-control and cohort studies [16]. Smoking during pregnancy 
increased the risk of offspring ADHD. The risk of ADHD was greater for children 
whose mothers were heavy smokers than for those mothers were light smokers. 
The authors suppose that there can be relationship between maternal smoking and 
ADHD in children but could not clarify if other confounding risk factors can affect 
on this causality. Thus it is necessary to perform more studies in order to detect 
association between maternal smoking and ADHD in offsprings.
2.1.8 Iodine deficiency and children with ADHD
Correlation of the Iodine deficiency and ADHD in children is of high interest. 
Thyroid hormones are necessary for the normal metabolic function and the Iodine 
is important element in the synthesis and regulation of thyroid hormones. It is well 
known that Iodine deficiency (ID) can lead to mental retardation although prevent-
able and the most critical period for this is fetal development. Maternal thyroid 
function and Iodine concentration of infant are strongly correlated and the group of 
disorders due to disturbances in this correlation are called ID disorders. According 
to Hope Abel and colleagues [17] maternal ID during pregnancy has direct associa-
tion with severe ADHD symptoms in offsprings at eight years of age. Although it 
is not recommended maternal iodine intake in order to avoid ADHD risk in child 
especially as it is known iodine supplementation in the first trimester is associated 
with an increased health risks
2.1.9 Lead exposure and ADHD
Lead (Pb) has as a neurotoxic effect leading to abnormal behavior in children. 
There are plenty of studies attempting to detect correlation between exposure 
to heavy metals and other harmful environmental factors in the pathogenesis of 
behavioral disorders. In 1991 recommended level of lead in children's blood (BLL) 
by CDC is set to 10 micrograms of lead per deciliter of blood (μg/dL) and it has not 
been changed since then. Donzelli et al. [18] performed systematic review of 17 
studies assessing the correlation of lead level and ADHD. According to their results 
there is a direct correlation between low lead level of lead in ADHD children’s blood 
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and severity of ADHD symptoms. However, we need more high quality clinical 
studies to prove this relationship.
Although evidence shows that ADHD is a worth recognizing disorder many 
environmental risk factors such as exposure to heavy metals, dietary factors, 
environmental exposure to different substances could intensify or accelerate the 
progression of this disease. The efforts for early diagnosis of the disease is crucial, 
and identifying the contributing factors is of prime importance to prevent ADHD.
Although evidence shows that ADHD is a worth recognizing disorder many 
environmental risk factors such as exposure to heavy metals, dietary factors, 
environmental exposure to different substances could intensify or accelerate the 
progression of this disease. The efforts for early diagnosis of the disease is crucial, 
and identifying the contributing factors is of prime importance to prevent ADHD.
2.2 Genetic factors
It has been implicated that genetic factors play a critical role in the etiology of 
ADHD as well as its comorbidities. Based on multiple familial, twin, adoption and 
single epidemiological studies ADHD is considered as one of the psychiatric dis-
orders which shows the strongest genetic basis. Several twin studies have revealed 
that concordance in monozygotic (MZ) twins is higher than in dizygotic (DZ) twins 
with heritability estimates of approximately 75–80%. Large numbers of linkage 
studies, genome wide association studies (GWAS) and meta-analyses have been 
conducted and numbers of susceptibility variants, genes and chromosomal regions 
have been reported to be associated with ADHD. Moreover, number of studies also 
shows that about one third of ADHD’s heritability is due to a polygenic component 
encompassing many common variants, where each variant individually has small 
effect but their cumulative effect contributes to the development of the condition. 
Investigation of copy number variants (CNVs) has also shown that rare insertions or 
deletions contribute to the part of ADHD’s heritability. Recent progress in identify-
ing ADHD susceptibility genes underlines new biological pathways that may have 
implication for prevention and treatment development.
According to the literature the mean heritability across multiple twin studies 
of ADHD is 74–80% [19, 20] and it is similar in ADHD males and females [21]. 
According to one study, where 894 probands with ADHD and their 1135 siblings 
were studied, there was nine-fold increased risk of ADHD in siblings of ADHD 
probands compared with siblings of controls. Several adoption studies also indi-
cate that ADHD is greater among the biological relatives of non-adopted ADHD 
children than adoptive relatives of adopted ADHD children and the risk for 
ADHD in adoptive relatives is similar to the risk in relatives of control children. 
Additionally, adoption studies suggest that the familial aggregation of ADHD 
is defined more by genetic factors rather than common environmental factors. 
Based on the largest longitudinal study to date on familial aggregation of ADHD, 
the closer was the relatedness of probands and their relatives the higher was the 
familial aggregation [20]. Consistently, among full siblings, the familial aggrega-
tion did not differ significantly by index person’s sex. Moreover, it is expected that 
genetic factors play more important role in explaining familial aggregation than 
shared environmental factors [22], given that the familial aggregation is remark-
ably higher in MZ twins than in DZ twins and similar between DZ twins and 
nontwin full siblings.
Genetic linkage was the first genome-wide method applied to ADHD. This 
method looks through the genome to find evidence that a segment of DNA is 
transmitted with a disorder within families. According to the literature there is no 
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clear-cut evidence about which chromosomal regions are linked to ADHD and so 
far none of the findings met genome-wide significance, suggesting that common 
DNA variants having a large effect on ADHD may not exist [23].
Genome-wide association studies (GWAS) scan the entire genome to detect 
common (frequency more than 1%) DNA variants that have very small etiologic 
effects. The early GWAS of ADHD did not discover any DNA variants that achieved 
genome-wide significance. However, recent studies have implicated contribution of 
some genes with relevant biological roles in ADHD. For example USP6 is involved 
in regulation of dopamine levels in the synapses and regulates neurotransmitter 
homeostasis. Certain variants in LINC00461 are associated with educational attain-
ment and ST3GAL3 and MEF2C are associated with ID and psychiatric disorders 
[24]. The GWAS analyses also showed that polygenic effects may also contribute 
to ADHD’s heritability, where multiple common risk variants each with very small 
effects contribute to the development of the disease as a cumulative effect. The 
polygenic nature of ADHD was confirmed by evaluating polygenic risk scores and 
revealing that it predicted ADHD, in a dose-dependent manner. The discovery of a 
polygenic susceptibility to ADHD does not show which DNA variants comprise the 
susceptibility, however significant findings implicate that genes involved in biological 
processes such as synaptic plasticity, catecholamine metabolic processes, G-protein 
signaling pathways, cell adhesion, neuronal morphogenesis and neuron migration 
were over-represented in ADHD. Moreover, many of these genes show considerable 
interactions with genes identified as trending towards significance in GWAS [25].
It has been known for a long time that rare DNA variants can lead to 
ADHD. Because chromosomal deletions and duplications often delete or duplicate 
a large segment of DNA which may include part of a gene or even several genes, 
they often have clear implications for gene functioning. Several studies indicate that 
there is a greater burden of large, rare CNVs among ADHD patients compared with 
controls [26]. Despite the fact that deletions and duplications are equivalently over-
represented in ADHD individuals, statistical significance for ADHD is observed 
only for duplications, as well as in schizophrenia and ASDs [27] Several well-known 
syndromes and chromosomal abnormalities may be associated with multiple 
medical and psychiatric problems along with ADHD. Among these are Klinefelter 
syndrome, Turner syndrome, 22q11 deletion syndrome, fragile-X syndrome, 
tuberous sclerosis, neurofibromatosis, Williams syndrome, as well as translocations 
involving SLC9A9, duplication of 7p15.2-15.3 and deletion of 15q13. It is noteworthy 
to mention that such larger chromosomal rearrangements show increased incidence 
of ADHD along with global developmental delay (GDD), intellectual disability 
(ID) and ASD [28]. Beside chromosomal abnormalities there is increasing evidence 
of single-gene contribution to ADHD, including inactivating mutation in TPH2, 
duplication of CHRNA7 and pathogenic changes in PARK2, FBXO33 and RNF122 
[29]. New technologies like next generation sequencing (NGS) and whole exome 
sequencing (WES) revealed several novel rare variants in candidate genes, among 
them TBC1D9, DAGLA, QARS, CSMD2, TRPM2, and WDR83, NT5DC1, SEC23IP, 
PSD, ZCCHC4, and BDNF [30].
It is clear that certain DNA variants increase the risk for ADHD. It is not com-
mon that only a single genetic alteration may cause ADHD in the absence of other 
DNA variants. At the same time it is clear that there are no common DNA variants 
that are necessary and sufficient causes of ADHD. GWAS show that a genetic 
susceptibility to ADHD encompasses of many common DNA variants, but yet we do 
not know exactly which variants or how many of them contribute to the polygenic 
nature. The heritability that cannot be explained by main effects of rare or com-
mon variants is likely due to gene-gene and gene-environment interactions. The 
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accumulating evidence for ADHD risk factors genes does not exclude the environ-
mental etiological factors which likely work through epigenetic mechanisms, but 
these yet have barely been studied in ADHD. In the coming years, we can expect 
breakthroughs in the genetics of ADHD. Unraveling the genetics of ADHD will not 
be easy, but with rapid development of technologies and with wider application and 
better interpretation of whole exome and whole genome sequencing (WGS) data 
the knowledge and significance of various rare and common variants will increase 
dramatically. Such advances will enable us to understand the etiology of ADHD and 
set forth opportunities to diagnose and treat the disorder.
2.3 Biological basis
Attention problems manifested in ADHD are due to dysfunction of ventral 
catecholaminergic pathways projecting to prefrontal and frontal cortex. More than 
thirty structural and functional neuroimaging studies in ADHD brain have been 
reported. The main area in the brain implicating in ADHD is prefrontal cortex and 
its innervations of subcotrical regions such as caudate-putamen, nucleus accum-
bens, and amygdala. Reduced size of corpus callosum has been detected in some 
children with ADHD and typically larger corpus callosum in the human female 
brain may be protective against ADHD. Cerebellum has been implicated in cogni-
tion and emotion besides the well-known role in coordination and maintaining body 
posture, suggesting a possible role contributing to ADHD that is consistent with 
reports of disorders of fine motor movements in ADHD children. Hippocampus as 
an important site for memory is also can be considered as possible participant in 
pathogenesis of ADHD. Structural brain imaging could not confirm the structural 
abnormalities of hippocampus but functional imaging found reduced cerebral 
glucose metabolism in hippocampus in adolescents with ADHD [31].
2.4 Neurobiology
The neurotransmitter dopamine has been recognized to play a role in attention 
and cognition especially executive functioning and reward processing [32]. It is a 
key contributor to behavioral adaptation.
Dopamine transporter is the most important molecule in the regulation of 
dopamine signaling in most areas of the brain-is the main target of stimulants 
like Methylphenidate and also dexamphetamine-drugs for ADHD treatment. 
These drugs block the dopamine transporter and lead to an increase in dopamine 
concentration particularly in the parts of the basal ganglia that are highest in the 
expression of the transporter, the striatum [33]. Positron emission tomography 
(PET) shows that people with ADHD have more dopamine transporter activity 
compared with healthy controls [34]. Besides genetic studies reveal that disorders 
in dopamine signaling could occur due to alteration in dopamine receptors which 
also has to be seen by PET. Meta analyses have shown significant involvement of 
dopamine transporter protein (DAT) and its gene- DAT1 gene 3’-regulatory region 
in a larger group of patients with ADHD suggested association of this set of genes 
with severity of symptoms in children with this disorder [35].
Norepinephrine signaling is related with dopamine system as norepineph-
rine is a downstream product of metabolism of dopamine. Innervation of the 
prefrontal cortex by norepinephrine pathways is very important to understand 
ADHD. Norepinephrine and dopamine signaling are linked in prefrontal cortex 
thus influencing each other in organizing prefrontal cortex performance in cog-
nitive tasks [36]. The role of norepinephrine can be explained by the fact that 
Mental Disorders
10
Methylphenidate and dexamphetamine inhibit the norepinephrine transporter 
together with DAT [36]. It is proved that altering norepinephrine signaling can 
improve ADHD symptoms but there is lack of evidence to link it with ADHD 
neurobiology [37].
Serotonin has been studied closely in animal models of ADHD. It was found 
that serotonin-potentiating agents can inhibit effects on motor hyperactivity [38]. 
Serotonin neurotransmission may modulate the severity of ADHD symptoms rather 
than being related to ADHD onset [39]. Other position means that it may be the 
comorbidity especially with conduct disorder, obsessive compulsive disorder and 
aggression and mood disorders rather than the core symptoms of ADHD which is 
influenced by serotonin [40]. Although serotonin receptor gene HTR1B and gene 
encoding the serotonin transporter (SLC6A4, 5-HTT, SERT) have been implicated 
in ADHD the effect of environment on ADHD symptoms may explain some of 
the observed inconsistency across studies especially the effect of stress on ADHD 
seems to be influences by genetic variation in the serotonin transporter gene [37]. In 
experimental models serotonin may be critically involved in mediating the behavior 
inhibiting effects of stimulants [41]. All these suggest that serotonin may play a role 
in pathogenesis in some circumstances but do not establish serotonin-enhancing 
drugs as useful treatment.
2.5 Main cognitive finding associated with ADHD
Cognitive impairments in a variety of domains have been found in ADHD as 
well as impairment in overall intellectual function. Deficit in executive function are 
common in children with ADHD. Executive functioning are the group of cognitive 
processes which are responsible for purposeful, goal-directed and problem solving 
behavior. A meta-analysis of children and adolescents with ADHD showed impair-
ments in several aspects of executive functioning.
2.5.1 Intellectual function
Visuospatial abilities (block-design subtest) and general knowledge (vocabu-
lary subtest) on the Wechsler Intelligence Scale for Children-III (WISC-III) have 
to be changed in children with ADHD compared with healthy controls. Children 
with predominantly inattention without hyperactivity have disorders of visuo-
spatial abilities. In contrast, the ADHD group predominantly with hyperactivity 
have the same evidence in visuospatial abilities or vocabulary as their healthy 
teens [1].
2.5.2 Language
Language can be impaired in ADHD children. A meta-analysis of children 
with ADHD found impairments in verbal fluency especially in phenomic fluency 
compared with semantic fluency [42]. Sometimes in adolescents with ADHD the 
disorders with object naming also can be revealed [43].
2.5.3 Learning and memory
Working memory is considered to be the most central executive function. 
Working memory disorders are quite variable in ADHD children. Mainly working 
memory is impaired and becomes the core feature of ADHD with the strongest 
impairments reported for the spatial domain of working memory as opposed to 
the verbal or phonological domain [44]. Visuospatial working memory is provided 
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predominantly by inferior and superior parietal areas together with dorsolateral 
prefrontal regions [45–48, 49], Cerebellum also can be activated during visuospa-
tial working memory tasks [50, 51]. Learning disorders also can be seen in ADHD 
children. Children with learning disorders and ADHD have more severe learning 
problems than children who have only ADHD. Learning disorder and attention 
problems are on continuum, are interrelated and usually coexist [52]. Comorbidity 
with learning disorders is a modifying factor in the health related quality of life of 
children with ADHD [4]. It was found that 5% of children have ADHD without 
learning disorder, 5% have learning disorder without ADHD and 4% have both 
conditions. Boys are more likely those girls to have each diagnosis. In 2006 approxi-
mately 4.5 million school aged children have ever been diagnosed with ADHD 
and 4.6 million children with learning disorders [53, 54]. Thus ADHD associated 
learning and language disabilities are important comorbidities. Neurological assess-
ment is recommended in children with learning disorder who fail to make academic 
progress despite appropriate educational intervention. The adolescents with ADHD 
experienced written expression impairment (17.2–22.4%) at a similar rate to reading 
impairment (17.0–24.3%) and at a slightly lower rate than mathematics impairment 
(24.7–36.3%) [4]. Dyslexia occurs in 5–10% of school children; it overlaps with 
ADHD and shows similar genetic characteristics but different brain localizations [4].
Another part of executive disorder is impairment of response inhibition. 
Response inhibition specifically is the ability to control oneself by suppressing or alter-
ing intended actions that are no longer required or appropriate. Thus normal response 
inhibition enables people to adapt properly to changes in the environment. Impaired 
response inhibition is central to theoretical models of ADHD [55]. According to 
Barkley [56] response inhibition is a central deficit of ADHD affecting top-down 
multiple executive functions including working memory, self-regulation, internal-
ization of speech and reconstitution. A large community study showed that ADHD 
symptoms in children and adolescents are associated with worse response inhibition 
and slower response latency [57]. Response inhibition deficit in ADHD is proved by 
magnetic resonance imaging (MRI). Healthy children activate core network of brain 
regions involved in response inhibition including a frontal-striatal and frontal-parietal 
network. Children and adolescents with ADHD show decreased activation in frontal, 
medial and parietal regions during inhibition compared with healthy teens [58].
Willcut et al [59] found impairments in other domains of executive functioning 
like planning and vigilance in addition to response inhibition and working memory. 
They noted that while impairment in executive functioning are closely associated 
with ADHD such deficits do not explain all of the cognitive impairments observed 
in ADHD suggesting that executive dysfunction is only one part of the cognitive 
impairments associated with ADHD [1].
Another frequently described comorbidity is disorder of cognitive flexibil-
ity. It is clear that ADHD children are more likely to respond with overlearned 
and automatic responses when faced with problem-solving situations or context 
that demand the thoughtful formation of strategies and the flexible shifting of 
thought [60]. Barkley et al [60] suggested that behavioral or verbal creativity 
can be impaired in children with ADHD as a consequence of their poor verbal 
inhibition.
Decision making can be considered as important part of executive functioning. 
ADHD children and adolescents have specific decision making deficits. ADHD people 
have no impaired learning rate per se as it was suggested before [61]. ADHD indi-
viduals exhibit less comprehensive decision process and more frequent exploration 
activity compared with controls. This feature could occur due to impaired reward 
prediction processing in the medial prefrontal cortex which is considered as an 
integrative hub in the brain responsible for decision making and learning. The deficit 
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in decision making in adolescents and adults was similar in severity to the deficits in 
attention in individuals with ADHD [62].
Reward sensitivity is an evolutionary important part of executive functioning. 
Rewards are accompanied by positive feeling and they reinforce reward linked 
behavior [37]. This process of reinforcing behavior forms the basic principle of 
learning [63]. Individuals with highly sensitive to rewards shows maladaptive 
behavior like risky behavior and addictions [37]. Theoretical model of ADHD con-
sider altered reward sensitivity as a main cognitive mechanism [64], Children and 
adolescents with ADHD are performing risky and suboptimal decisions. ADHD 
population with impaired reward processing and impulsivity show increased 
activations in the anterior cingulated and anterior frontal cortex as well as in 
orbitofrontal cortex and nucleus accumbens [65]. Other studies in ADHD adoles-
cents have reported less triatal activation during reward compared with healthy 
teens [66].
Specific motor deficits may be found in children with ADHD but like other mea-
sures of neuropsychological functioning, such difficulties are not specific predictors 
of the presence of ADHD [67]. Commonly difficulties can be seen in coordina-
tion. When both attention and coordination deficits co occur in conjunction with 
perceptual problems the term “deficit in attention, motor control and perception 
(DAMP)” can be applied [68]. The concept of DAMP is fairly controversial and the 
label is more widely used in Scandinavian countries than in UK or USA.
2.5.4 Treatment
The most important part of any intervention plan for a child with ADHD is the 
physical, behavioral and neuromotor/neuropsychological examination followed by 
oral and written information of parents, child, teacher about the type of problems 
the child exhibits and their possible etiology.
Special education- many children with ADHD need special educational mea-
sures. In order to acquire some academic skill some children will need individual-
ized education lasting for several hours every day [69].
The two most commonly used behavioral interventions are:
1. Creating and maintaining a well structured environment to compensate for 
poor stimulus control
2. Parent training
It is very important to organize the school environment with minimal distrac-
tions and with seating that is somewhat isolated and close to the front of the 
classroom in front of the teacher. Common triggers that can easily distract child are 
instructional demand, withholding of a desired object or activity and withdrawal of 
parental attention.
Behavior therapy can be considered as the best method for treatment of ADHD 
children and youths regarding the improvement of behavior, self-control and self-
esteem. It is recommended for parents of children younger than 12 years of age to 
start training in behavior therapy. For children less than 6 years of age it is better to 
start behavior therapy before prescribing ADHD medicine. Behavior therapy helps 
parents to learn skills and strategies to improve their children academic achieve-
ment at school, behavior at home and improve their social interaction. Although 
studying and practicing of behavioral therapy needs time and effort from parents 
the sequence benefit for the child and family could last for a long period of time. 
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Parent training in behavior management is also known as parent behavior therapy, 
behavioral parent training or just parent training. If possible, families should look 
for a therapist who focuses on training parents. Some therapists will have training 
or certification in a parent training program that has been proven to work in young 
children with ADHD.
The following are the main goals for therapist while working with parents:
• Parents need to know how to make positive reinforcement, how to construct and 
control child’s behavior. Thus they need to acquire these skills and strategies.
• Parents need to be aware how to interact and communicate with their 
ADHD children
• Therapists needs to teach parents practical skill how to work with their child
• Therapist needs to meet with family members to observe the progress in their 
activity and to provide support
• Therapist needs to re-evaluate treatment strategy and method and in case if it 
is needed to change strategy plans.
3. What can parents expect?
It is recommended for parents to attend eight or more session with a therapist 
who can work with groups of parents or only with one family. It is necessary to work 
on a regular basis in order to monitor progress of parents and to change the working 
strategy in case if it needed. Parents’ role in treatment planning and implementing 
is extremely crucial as they can have greatest influence on their child’s behavior. 
There are many treatment options for therapist for working with ADHD children. 
Play therapy and talk therapy could be considered as one of the best treatment 
option. Talk therapy uses verbal communication between ADHD child and thera-
pist in order to improve child’s emotional state. Although behavioral therapy needs 
time and effort its effect could last for long period of time [70].
Successful treatment for ADHD means both behavior therapy and medication. 
For children 6 years of age and older, the American Academy of Pediatrics (AAP) 
recommends both behavior therapy and medication. For children under 6 years of 
age behavior therapy is recommended as the first line of treatment [71].
Medication should be start with one of the stimulants. Both d-amphetamine 
(10–40 mg/day given in 2–5 dosed with 3-hour intervals in order to last through 
the school day) and methylphenidate (20–80 mg/day given in the same fashion) 
have been shown to be effective for improvement of hyperactivity, concentration 
problems, learning disorders and other comorbidities. Both drugs have minimal 
side effects. “Long-acting,” “slow-release” preparations of methylphenidate have 
also been shown to have good effects and they can sometimes be dosed (18–54 mg/
day or 10–60 mg/day depending on preparation) only once daily. Relatively com-
mon side effects are loss of appetite, a tendency to increase the likelihood of tics and 
stereotypies, reduced mimicry and hallucinations. They can easily stop with drug 
discontinuation. There are some evidence that long-term methylphenidate treatment 
should be as effective as the combination of methylphenidate and behavioral therapy 
and considerably more effective than behavioral therapy alone [72]. Combination of 
methylphenidate and behavioral therapy is the best choice for improving both ADHD 
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and ADHD plus depression and anxiety. Doctor should be careful for monitoring the 
child’s height, drug dependency while treating the child with stimulants for long term 
period although they appear rare compared with tricyclic antidepressants.
The noradrenergic reuptake inhibitor atomoxetine has also been shown to have ben-
eficial effects on ADHD as a second line treatment in children with ADHD. Although 
clinical effects appear to be less effective than with methylphenidate but the advantage 
if this medication is that it can be used only once daily and it is not stimulant [69].
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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